OKYO Pharma (OKYO) Accounts Payables (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Accounts Payables data on file, last reported at $7.6 million in Q3 2025.

• Accounts Payables for Q3 2025 came in at $7.6 million, down 20.48% year-over-year; the trailing twelve-month figure through Sep 2025 was $7.6 million (down 20.48% YoY), and the FY2025 annual result was $8.4 million, up 18.48% from the prior year.
• Accounts Payables eased to $7.6 million in Q3 2025 per OKYO's latest filing, from $8.4 million in the prior quarter.
• Over five years, Accounts Payables peaked at $9.6 million in Q3 2024 and troughed at $1.3 million in Q1 2022.
• A 5-year average of $5.7 million and a median of $6.2 million in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables decreased 21.93% in 2022, then soared 226.37% in 2023.
• A 5-year view of Accounts Payables shows it stood at $1.7 million in 2021, then retreated by 21.93% to $1.3 million in 2022, then soared by 315.15% to $5.4 million in 2023, then surged by 77.17% to $9.6 million in 2024, then fell by 20.48% to $7.6 million in 2025.
• Business Quant data shows OKYO's Accounts Payables at $7.6 million in Q3 2025, $8.4 million in Q1 2025, and $9.6 million in Q3 2024.